In the article by Kim et al (Kim BJ, Han M-K, Park TH, Park S-S, Lee KB, Lee B-C, Yu K-H, Oh MS, Cha JK, Kim D-H, Lee J, Lee SJ, Ko Y, Park J-M, Kang K, Cho Y-J, Hong K-S, Kim J-T, Choi JC, Kim D-E, Shin D-I, Kim W-J, Lee J, Lee JS, Yoon B-W, Gorelick PB, Bae H-J. Low-versus standard-dose alteplase for ischemic strokes within 4.5 hours: a comparative effectiveness and safety study. Stroke. 2015:46:2541–2548. DOI: 10.1161/STROKEAHA.115.010180.), which published online ahead of print on August 4, 2015, and appeared in the September 2015 issue of the journal, a correction was needed.
On page 2545, the second sentence of the Discussion, “The adjusted frequency of achieving an mRS score 0 to 1 at 3 months after stroke onset was 36% in the low-dose alteplase group and 32% in the standard-dose group,” has been changed to read, “The adjusted frequency of achieving an mRS score 0 to 1 at 3 months after stroke onset was 35% in the low-dose alteplase group and 33% in the standard-dose group.”
This correction has been made to the online version of the article, which is available at http://stroke.ahajournals.org/content/46/9/2541.
- © 2015 American Heart Association, Inc.